Literature DB >> 8349944

Therapy for patients with recurrent infections and low serum IgG3 levels.

I B Barlan1, R S Geha, L C Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8349944     DOI： 10.1016/0091-6749(93)90179-j

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

Review 1.  Immunity, infection, and nasal disease.

Authors:  S H Yoshida; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  1998 Spring-Summer       Impact factor: 8.667

Review 2.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

3.  Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy.

Authors:  F Abrahamian; S Agrawal; S Gupta
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

4.  Pneumococcal vaccination responses in adults with subnormal IgG subclass concentrations.

Authors:  Antony R Parker; Markus Skold; Stephen Harding; J Clayborn Barton; Luigi F Bertoli; James C Barton
Journal:  BMC Immunol       Date:  2019-08-20       Impact factor: 3.615

Review 5.  Therapeutic use of immunoglobulins.

Authors:  E Richard Stiehm; Jordan S Orange; Mark Ballow; Heather Lehman
Journal:  Adv Pediatr       Date:  2010

6.  Coming together at the hinges: Therapeutic prospects of IgG3.

Authors:  Thach H Chu; Edward F Patz; Margaret E Ackerman
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

7.  Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency.

Authors:  Bas M Smits; Ilona Kleine Budde; Esther de Vries; Ineke J M Ten Berge; Robbert G M Bredius; Marcel van Deuren; Jaap T van Dissel; Pauline M Ellerbroek; Michiel van der Flier; P Martin van Hagen; Chris Nieuwhof; Bram Rutgers; Lieke E A M Sanders; Anna Simon; Taco W Kuijpers; Joris M van Montfrans
Journal:  J Clin Immunol       Date:  2020-11-18       Impact factor: 8.317
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.